[go: up one dir, main page]

WO2004046732A8 - Methodes de criblage de composes modulant le flux de cholesterol et utilisations - Google Patents

Methodes de criblage de composes modulant le flux de cholesterol et utilisations

Info

Publication number
WO2004046732A8
WO2004046732A8 PCT/FR2003/003303 FR0303303W WO2004046732A8 WO 2004046732 A8 WO2004046732 A8 WO 2004046732A8 FR 0303303 W FR0303303 W FR 0303303W WO 2004046732 A8 WO2004046732 A8 WO 2004046732A8
Authority
WO
WIPO (PCT)
Prior art keywords
methods
screening compounds
modulating cholesterol
compounds modulating
cholesterol flux
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2003/003303
Other languages
English (en)
Other versions
WO2004046732A1 (fr
Inventor
Guilhem Larigauderie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit SA filed Critical Genfit SA
Priority to AU2003292347A priority Critical patent/AU2003292347A1/en
Publication of WO2004046732A1 publication Critical patent/WO2004046732A1/fr
Publication of WO2004046732A8 publication Critical patent/WO2004046732A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention décrit des méthodes de sélection, identification ou caractérisation de composés capables de moduler le flux de cholestérol comprenant la détermination d'une modulation de l'activité de l'adipophiline. Elle concerne également des procédés de prépar ations de médicaments.
PCT/FR2003/003303 2002-11-15 2003-11-05 Methodes de criblage de composes modulant le flux de cholesterol et utilisations Ceased WO2004046732A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003292347A AU2003292347A1 (en) 2002-11-15 2003-11-05 Methods for screening compounds modulating cholesterol flux and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0214345A FR2847266A1 (fr) 2002-11-15 2002-11-15 Methodes de criblage de composes modulant le flux de cholesterol et utilisations
FR02/14345 2002-11-15

Publications (2)

Publication Number Publication Date
WO2004046732A1 WO2004046732A1 (fr) 2004-06-03
WO2004046732A8 true WO2004046732A8 (fr) 2005-04-07

Family

ID=32187650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/003303 Ceased WO2004046732A1 (fr) 2002-11-15 2003-11-05 Methodes de criblage de composes modulant le flux de cholesterol et utilisations

Country Status (3)

Country Link
AU (1) AU2003292347A1 (fr)
FR (1) FR2847266A1 (fr)
WO (1) WO2004046732A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261760B1 (en) * 1998-03-09 2001-07-17 The Regents Of The University Of California Regulation of the cell cycle by sterols
AU784108B2 (en) * 1999-03-15 2006-02-02 University Of British Columbia, The Methods and reagents for modulating cholesterol levels
AU1683801A (en) * 1999-11-16 2001-05-30 Hamilton Civic Hospitals Research Development, Inc. Methods and compositions for modulating er-stress-induced cholesterol/triglyceride accumulation

Also Published As

Publication number Publication date
WO2004046732A1 (fr) 2004-06-03
FR2847266A1 (fr) 2004-05-21
AU2003292347A1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
WO2004037159A3 (fr) Composes, compositions et methodes permettant de moduler le metabolisme des graisses
AU2003293015A1 (en) Microporous materials, methods, and articles for localizing and quantifying analytes
WO2002099048A3 (fr) Genes limk en tant que modificateurs de la voie p53 et procedes d'utilisation associes
MXPA03004754A (es) Cartucho para discos.
WO2004078995A3 (fr) Methodes de modulation et d'identification d'agents modulant le calcium intracellulaire
WO2005051178A3 (fr) Marqueur pour la neuromyelite optique
WO2004001375A8 (fr) Marqueurs de produits multifonctionnels et procedes de fabrication et d'utilisation de ces marqueurs
WO2004020458A3 (fr) Tests et compositions d'identification d'agents modulant l'activite d'agents de desubiquitination
WO2005028678A3 (fr) Procedes et materiaux permettant d'identifier des agents modulant le remodelage osseux, et agents ainsi identifies
WO2001023412A3 (fr) Procedes de criblage d'agents inhibiteurs de l'agregation des polypeptides
WO2004048552A3 (fr) Modulation de reponses immunitaires
WO2007094755A3 (fr) Compositions et procédés de modulation de la fonction cognitive
WO2000052194A3 (fr) Procede pour detecter une activite de caspase due a une membrane et modulateurs conçus a cet effet
AU2003258454A1 (en) Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
WO2005051423A3 (fr) Procedes et agents pour mettre en oeuvre une modulation immunitaire et procedes d'identification de modulateurs immunitaires
MXPA05001690A (es) Estrategia de deteccion para farmacos anticancer.
AU2002306748A1 (en) Anti-gpe antibodies, their uses, and analytical methods for gpe
WO2004046732A8 (fr) Methodes de criblage de composes modulant le flux de cholesterol et utilisations
WO2003017817A3 (fr) Diagnostic, prevention et traitement du cancer
AU2002364612A8 (en) Methods and materials for modulating enac-beta
AU2003253593A1 (en) Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
WO2005055942A3 (fr) Modulation des voies et de fonction cerebrales
AU2002234729A1 (en) Method for identifying compounds modulating reverse cholesterol transport
WO2002031115A3 (fr) Molecules d'acide nucleique et polypeptides aux fins d'une immunomodulation
WO2003029409A3 (fr) Procedes permettant de produire, selectionner et identifier des composes fixant une molecule cible

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA US

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 23/2004 ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV)) FOR US ONLY."